Richard H. De Boer
Grattan St
Parkville, NSW 3050, Australia
Parkville, NSW 3050, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
Real-world outcomes in patients with hormone receptor positive, human epidermal growth factor receptor 2 receptor-negative advanced breast cancer and visceral metastases at baseline - advanced hormone receptor positive breast cancer registry in Australia.
Journal: Internal medicine journal
Published: January 14, 2026
Palbociclib in the Treatment of HR+/ HER2- Advanced or Metastatic Breast Cancer in Australia: A Real-World Retrospective Analysis.
Journal: Asia-Pacific journal of clinical oncology
Published: May 05, 2025
Current usage of pembrolizumab in triple negative breast cancer (TNBC).
Journal: Expert review of anticancer therapy
Published: April 10, 2024
Medicine Access Programmes: what do patients think - a patient-reported outcome study on ribociclib in metastatic breast cancer in Australia.
Journal: Internal medicine journal
Published: February 16, 2024
Evaluating a Remotely Delivered Cardio-Oncology Rehabilitation Intervention for Patients With Breast Cancer (REMOTE-COR-B): Protocol for a Single-Arm Feasibility Trial.
Journal: JMIR research protocols
Published: October 02, 2023
Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 27, 2023
Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer.
Journal: Breast cancer research and treatment
Published: July 18, 2022
Real-World Outcomes of Ribociclib and Aromatase Inhibitor Use in First Line Hormone Receptor Positive, HER2-Negative Metastatic Breast Cancer.
Journal: Clinical breast cancer
Published: July 16, 2022
Pertuzumab study in the neoadjuvant setting for HER2-positive nonmetastatic breast cancer in Australia (PeRSIA).
Journal: International journal of cancer
Published: June 26, 2022
Real-World Outcomes in Patients With Brain Metastases Secondary to HER2-Positive Breast Cancer: An Australian Multi-centre Registry-based Study.
Journal: Clinical breast cancer
Published: February 26, 2022
Brief Report: Exploratory Analysis of Maintenance Therapy in Patients With Extensive-Stage SCLC Treated First Line With Atezolizumab Plus Carboplatin and Etoposide.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: January 12, 2022
Matching-Adjusted Indirect Comparison of Ribociclib Plus Fulvestrant versus Palbociclib Plus Letrozole as First-Line Treatment of HR+/HER2- Advanced Breast Cancer.
Journal: Cancer management and research
Published: July 15, 2021
Last Updated: 09/26/2026